Neuromod (Lenire) Clinical Trial Data “Locked” Until Fall 2020? Study Results “Delayed” Until 2021?

When will Neuromod publish the results of their latest clinical trial, Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2 (TENT-A2)?

It looks like we now have an answer…

The data collection and database lock are expected to be completed by February 2020, and the data analysis and manuscript submission are expected to be conducted in autumn of 2020.

The findings of this study will be disseminated to relevant research, clinical, and health services and patient communities through publications in peer-reviewed journals and presentations at scientific and clinical conferences.

The source of this information, published on September 27, 2019:

https://www.ncbi.nlm.nih.gov/pubmed/31573942?dopt=Abstract
https://www.researchprotocols.org/2019/9/e13176/

Conlon B, Hamilton C, Hughes S, Meade E, Hall DA, Vanneste S, Langguth B, Lim HH
Noninvasive Bimodal Neuromodulation for the Treatment of Tinnitus: Protocol for a Second Large-Scale Double-Blind Randomized Clinical Trial to Optimize Stimulation Parameters
JMIR Res Protoc 2019;8(9):e13176
DOI: 10.2196/13176
PMID: 31573942

Neuromod/Lenire Results… 2021?

Why the long wait?

The time between manuscript submission and publication is usually a matter of months.

For example, The Proceedings of the National Academy of Sciences (PNAS) website mentions that the average time from submission to online publication for their journal is 5.5 months and the average time from submission to issue publication is 6 months.

The wait time varies depending on the publication, but you get the idea…

Even if Neuromod submits their manuscript in late 2020 – as currently planned – that still means we probably won’t see the actual findings and published article until Q1 2021 or Q2 2021… or maybe later…

So despite all those exciting Hubert Lim videos and teasers, it seems like we are not going to get the TENT-A2 results for another year or more.

(Prove us wrong, Neuromod, prove us wrong!)

Meanwhile, the company continues to prepare for global commercialisation of their Lenire tinnitus treatment.


What do you think? Head on over to TinnitusTalk, r/tinnitus, r/tinnitusresearch, or your favorite tinnitus forum and/or Facebook group and discuss this update.

And remember to subscribe to TinnitusTreatmentReport.com email updates for more exclusive tinnitus treatment-related updates and the latest research. (First newsletter issue coming soon.)

Questions? Comments? Corrections? Email michael@urgentresearch.com and say hello.


Subscribe to Email Updates

Newsletter subscribers get early access to our latest articles. Expect 1 to 3 emails per week.

This field is for validation purposes and should be left unchanged.

No spam, no third parties, and 100% free. Your information is kept private. Unsubscribe with one click anytime.